Problems and prospects for finding new pharmacological agents among adenosine receptor agonists, antagonists, or their allosteric modulators for the treatment of cardiovascular diseases

Biomed Khim. 2023 Dec;69(6):353-370. doi: 10.18097/PBMC20236906353.

Abstract

A1-adenosine receptors (A1AR) are widely distributed in the human body and mediate many different effects. They are abundantly present in the cardiovascular system, where they control angiogenesis, vascular tone, heart rate, and conduction. This makes the cardiovascular system A1AR an attractive target for the treatment of cardiovascular diseases (CVD). The review summarizes the literature data on the structure and functioning of A1AR, and analyzes their involvement in the formation of myocardial hypertrophy, ischemia-reperfusion damage, various types of heart rhythm disorders, chronic heart failure, and arterial hypertension. Special attention is paid to the role of some allosteric regulators of A1AR as potential agents for the CVD treatment.

Keywords: A1-adenosine receptors; agonists; antagonists and allosteric modulators of A1-adenosine receptors; cardiovascular diseases.

Publication types

  • Review

MeSH terms

  • Cardiovascular Diseases* / drug therapy
  • Humans
  • Purinergic P1 Receptor Agonists*

Substances

  • Purinergic P1 Receptor Agonists